US · Healthcare · Biotechnology
EPS came in at -0.60 against a street estimate of -0.12 — a miss of 400.0%.
Analysts rate DBV Technologies a hold (2 buy, 0 hold, 1 sell out of 3) with an average price target of $41.38.
| Fund | Stake |
|---|---|
| MPM Oncology Impact Management LP | 5.83% |
| Siren, L.L.C. | 2.96% |
| Vivo Capital, LLC | 2.94% |
| Baker Bros Advisors LP | 2.33% |
| Artisan Partners Limited Partnership | 2.18% |
| ADAR1 Capital Management LLC | 1.61% |
| Perceptive Advisors LLC | 1.53% |
| Logos Global Management LP | 1.46% |
| Document | Date |
|---|---|
| Quarterly report · Q2 2026 DBV TECHNOLOGIES S.A. – Q2 2026 10-Q SUMMARY HEADLINE NUMBERS • Cash position: $174.9 million as of June 30, 2026 (down from $194.2 million at Decem | 2026-07-16 |
| Results announced · Q3 2026 DBV TECHNOLOGIES – H1 2026 FINANCIAL RESULTS SUMMARY HEADLINE NUMBERS • Cash position: $174.9 million as of June 30, 2026 • Funding runway: Into thi | 2026-07-16 |
| Company announcement · Q2 2026 DBV TECHNOLOGIES S.A. - 8-K SUMMARY HEADLINE NUMBERS • Company: DBV Technologies S.A., France-based biopharmaceutical company • Stock listing: Americ | 2026-06-29 |
| Board / officer change · Q2 2026 DBV TECHNOLOGIES S.A. – 8-K SUMMARY HEADLINE NUMBERS • CEO Daniel Tassé granted 4,060,000 Performance Share Units (PSUs) on June 5, 2026 • 2,900,000 | 2026-06-05 |
| Charter / bylaws change · Q2 2026 DBV TECHNOLOGIES S.A. – 8-K FILING SUMMARY (JUNE 3, 2026) HEADLINE NUMBERS • Annual General Meeting held June 3, 2026 with 39 shareholder proposals | 2026-06-03 |
| Proxy statement · Q2 2026 DBV TECHNOLOGIES S.A. — PROXY STATEMENT SUMMARY --- CEO COMPENSATION • Daniel Tassé (Chief Executive Officer) received total compensation of €850,0 | 2026-05-11 |
| Quarterly report · Q1 2026 DBV TECHNOLOGIES S.A. – Q1 2026 10-Q SUMMARY HEADLINE NUMBERS • Cash position: $229.2 million as of March 31, 2026 (up from $194.2 million December | 2026-04-30 |
| Annual report FY2025 DBV TECHNOLOGIES S.A. – FORM 10-K SUMMARY Fiscal Year Ended December 31, 2025 --- HEADLINE NUMBERS • Market Capitalization (as of June 30, 2025): $ | 2026-03-26 |
Readable in the app.
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for DBV Technologies — free to start.
Google PlayApp StoreData updated 2026-09-18.